Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Content provided by TheoryLab and American Cancer Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TheoryLab and American Cancer Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Reducing barriers to patient enrollment in cancer clinical trials
MP3•Episode home
Manage episode 276643446 series 2681705
Content provided by TheoryLab and American Cancer Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TheoryLab and American Cancer Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Clinical trials are the key step in advancing potential new cancer treatments out of the lab and into the clinic. Patient participation in trials is crucial to this success. But only a small fraction of patients end up enrolling in a cancer clinical trial due to barriers that make participation difficult or even impossible. As a result, approximately 20% of cancer clinical trials fail due to insufficient patient enrollment. Understanding and addressing these barriers is critical to accelerating progress in cancer research. Mark Fleury, PhD, is Policy Principal at ACS CAN – the American Cancer Society Cancer Action Network (https://www.fightcancer.org/). Dr. Fleury joined the podcast to help us understand where we are falling short and how we can reduce these barriers to patient enrollment in clinical trials. 5:36 – What is ACS CAN? 7:55 – A recent piece of cancer-related legislation where ACS CAN was involved that he is particularly proud of 13:07 – Why clinical trials in cancer research are so important to patients 16:23 – On barriers to clinical trial enrollment: ACS CAN resources note that “approximately 20% of cancer clinical trials fail due to insufficient patient enrollment.” Why are we falling short? 22:50 – Some of the recommendations ACS CAN has helped identify that would reduce barriers to enrollment in cancer clinical trials 27:04 – How clinical trial matching services could be improved 32:38 – On disparities in clinical trial participation
…
continue reading
139 episodes
MP3•Episode home
Manage episode 276643446 series 2681705
Content provided by TheoryLab and American Cancer Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TheoryLab and American Cancer Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Clinical trials are the key step in advancing potential new cancer treatments out of the lab and into the clinic. Patient participation in trials is crucial to this success. But only a small fraction of patients end up enrolling in a cancer clinical trial due to barriers that make participation difficult or even impossible. As a result, approximately 20% of cancer clinical trials fail due to insufficient patient enrollment. Understanding and addressing these barriers is critical to accelerating progress in cancer research. Mark Fleury, PhD, is Policy Principal at ACS CAN – the American Cancer Society Cancer Action Network (https://www.fightcancer.org/). Dr. Fleury joined the podcast to help us understand where we are falling short and how we can reduce these barriers to patient enrollment in clinical trials. 5:36 – What is ACS CAN? 7:55 – A recent piece of cancer-related legislation where ACS CAN was involved that he is particularly proud of 13:07 – Why clinical trials in cancer research are so important to patients 16:23 – On barriers to clinical trial enrollment: ACS CAN resources note that “approximately 20% of cancer clinical trials fail due to insufficient patient enrollment.” Why are we falling short? 22:50 – Some of the recommendations ACS CAN has helped identify that would reduce barriers to enrollment in cancer clinical trials 27:04 – How clinical trial matching services could be improved 32:38 – On disparities in clinical trial participation
…
continue reading
139 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.